Cost-Utility Analysis of Nivolumab Monotherapy for Metastatic Melanoma Treatment
Abstract
Authors
M Echave A Soria L de la Cruz-Merino A Arance M Carrasco P González García
M Echave A Soria L de la Cruz-Merino A Arance M Carrasco P González García
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now